Robin A. Lacour

859 total citations
21 papers, 579 citations indexed

About

Robin A. Lacour is a scholar working on Oncology, Genetics and Obstetrics and Gynecology. According to data from OpenAlex, Robin A. Lacour has authored 21 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Genetics and 6 papers in Obstetrics and Gynecology. Recurrent topics in Robin A. Lacour's work include BRCA gene mutations in cancer (6 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Ovarian cancer diagnosis and treatment (5 papers). Robin A. Lacour is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Ovarian cancer diagnosis and treatment (5 papers). Robin A. Lacour collaborates with scholars based in United States, Sweden and Puerto Rico. Robin A. Lacour's co-authors include Karen H. Lu, Shannon N. Westin, Diana L. Urbauer, Diane C. Bodurka, Russell R. Broaddus, Larissa A. Meyer, Rajyalakshmi Luthra, Molly S. Daniels, Kathleen M. Schmeler and Charlotte C. Sun and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

Robin A. Lacour

21 papers receiving 569 citations

Peers

Robin A. Lacour

GENET

ONCOL

PFM

Simona Moroni Italy

Anne Goverde Netherlands

M J E Mourits Netherlands

Laura L. Holman United States

Michaela Onstad United States

François Laffargue France

Deborah J. Goldfrank United States

Heli Lyytinen Finland

Amy L. Gross United States

Kristin G. White United States

Simona Moroni Italy

Robin A. Lacour

162 ×0.8

GENET

328 ×1.7

180 ×1.0

ONCOL

58 ×0.3

PFM

229 ×1.5

Citations per year, relative to Robin A. Lacour Robin A. Lacour (= 1×) peers Simona Moroni

Countries citing papers authored by Robin A. Lacour

Since Specialization

Citations

This map shows the geographic impact of Robin A. Lacour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin A. Lacour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin A. Lacour more than expected).

Fields of papers citing papers by Robin A. Lacour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin A. Lacour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin A. Lacour. The network helps show where Robin A. Lacour may publish in the future.

Co-authorship network of co-authors of Robin A. Lacour

This figure shows the co-authorship network connecting the top 25 collaborators of Robin A. Lacour. A scholar is included among the top collaborators of Robin A. Lacour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin A. Lacour. Robin A. Lacour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lacour, Robin A., et al.. (2018). Malignant granular cell tumors: the role of electron microscopy in the definitive diagnosis of an extremely aggressive soft tissue neoplasm. Ultrastructural Pathology. 42(3). 304–311. 3 indexed citations

Lacour, Robin A., et al.. (2015). Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation. Archives of Gynecology and Obstetrics. 293(3). 659–665. 23 indexed citations

Westin, Shannon N., Charlotte C. Sun, Celestine S. Tung, et al.. (2015). Survivors of gynecologic malignancies: impact of treatment on health and well-being. Journal of Cancer Survivorship. 10(2). 261–270. 59 indexed citations

Tung, Celestine S., Charlotte C. Sun, Robin A. Lacour, et al.. (2013). Sleep disturbances: A critical issue among gynecologic cancer survivors. Gynecologic Oncology. 130(1). e7–e7. 1 indexed citations

Burzawa, Jennifer K., Kathleen M. Schmeler, Pamela T. Soliman, et al.. (2012). Evaluation of insulin resistance among endometrial cancer patients. Gynecologic Oncology. 127(1). S8–S8. 2 indexed citations

Lacour, Robin A., Elizabeth D. Euscher, E. Neely Atkinson, et al.. (2011). A Phase II Trial of Paclitaxel and Carboplatin in Women With Advanced or Recurrent Uterine Carcinosarcoma. International Journal of Gynecological Cancer. 21(3). 517–522. 29 indexed citations

Westin, Shannon N., Charlotte C. Sun, Karen H. Lu, et al.. (2010). Satisfaction with ovarian carcinoma risk‐reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer. 117(12). 2659–2667. 23 indexed citations

Clements, Aine, Elizabeth D. Euscher, Robin A. Lacour, et al.. (2010). The Presence of Human Papillomavirus or p16 in Six Cases of Retroperitoneal Carcinoma. Obstetrics and Gynecology. 116(5). 1042–1046. 8 indexed citations

Meyer, Larissa A., Robin A. Lacour, Molly S. Daniels, et al.. (2010). Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations. Obstetrics and Gynecology. 115(5). 945–952. 98 indexed citations

10.

Zhang, Qian, Qi Shen, Joseph Celestino, et al.. (2009). Enhanced estrogen-induced proliferation in obese rat endometrium. American Journal of Obstetrics and Gynecology. 200(2). 186.e1–186.e8. 61 indexed citations

11.

Westin, Shannon N., Russell R. Broaddus, Lei Deng, et al.. (2009). Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression. Cancer Biology & Therapy. 8(22). 2126–2135. 25 indexed citations

12.

Lacour, Robin A., Molly S. Daniels, Shannon N. Westin, et al.. (2008). What women with ovarian cancer think and know about genetic testing. Gynecologic Oncology. 111(1). 132–136. 54 indexed citations

13.

Meyer, Larissa A., Shannon N. Westin, Robin A. Lacour, et al.. (2008). Evaluating women with ovarian cancer for BRCA 1/2: Missed opportunities. Journal of Clinical Oncology. 26(15_suppl). 5532–5532. 1 indexed citations

14.

Westin, Shannon N., Robin A. Lacour, Diana L. Urbauer, et al.. (2008). Carcinoma of the Lower Uterine Segment: A Newly Described Association With Lynch Syndrome. Journal of Clinical Oncology. 26(36). 5965–5971. 142 indexed citations

15.

Lacour, Robin A.. (2008). Response to chemotherapy, recurrence and survival in advanced-stage ovarian, fallopian tube and primary peritoneal cancer patients with non-Ashkenazi Jewish BRCA mutations, compared to those without. DigtalCommons @ Texas Medical Center Library (Texas Medical Center). 2 indexed citations

16.

Milam, Michael R., Jian Gu, Haopeng Yang, et al.. (2007). STK15 F31I polymorphism is associated with increased uterine cancer risk: A pilot study☆. Gynecologic Oncology. 107(1). 71–74. 21 indexed citations

17.

Milam, Michael R., Jian Gu, Hushan Yang, et al.. (2007). STK15 F31I polymorphisms and uterine cancer risk: A case-control analysis. Journal of Clinical Oncology. 25(18_suppl). 5511–5511. 1 indexed citations

18.

Ramondetta, Lois M., Robin A. Lacour, Elizabeth D. Euscher, et al.. (2007). A phase II multicenter trial of paclitaxel and carboplatin in women with advanced or recurrent malignant mixed müllerian tumors (MMMT) of the uterus. Journal of Clinical Oncology. 25(18_suppl). 5589–5589. 4 indexed citations

19.

Lacour, Robin A., Elizabeth Garner, Kelly L. Molpus, Raheela Ashfaq, & John O. Schorge. (2005). Management of cervical adenocarcinoma in situ during pregnancy. American Journal of Obstetrics and Gynecology. 192(5). 1449–1451. 10 indexed citations

20.

Gharib, C, M. Vincent, G. Annat, et al.. (1981). [Plasma renin activity (PRA) and aldosterone (PA) during submaximal exercise. Effect of training (author's transl)].. PubMed. 77(8). 911–4. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact